BGI?s RT-PCR SARS-CoV-2 Test Now Commercially Available for Clinical Use in the United States
Rapid and Scalable RT-PCR Assay is Pending Approval for Emergency Use Authorization
- BGI?s test already has approvals through CE-IVD and China?s NMPA
- Kits are currently being distributed to more than 50 countries and regions worldwide
- Highly sensitive and quick test with 3-hour turnaround time